Zefen Xiao

18PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursSocial epidemiologyPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 15, 2025
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.

Weiming Han, Linrui Gao, Xiaomin Wang

|Sep 04, 2025
A nomogram for predicting the risk of chemoradiotherapy-associated thrombocytopenia in patients with esophageal cancer: a real-world cohort study.

Jia-Xuan Yang, Si-Yu Zuo, Jie Yang

|Feb 13, 2025
Multi-Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma.

Fangdong Zhao, Qifeng Wang, Weiming Han

|Jun 17, 2024
Two distinct age-prognosis patterns in patients with esophageal cancer undergoing surgical and radiotherapy treatments: a combined analysis of 3JECROG and SEER databases.

Chen Li, Xiao Chang, Qifeng Wang

|Nov 03, 2022
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.

Weiming Han, Lan Wang, Chen Li

|Nov 01, 2022
Radiation Dose-Effect Relation in Patients with Esophageal Squamous Cell Carcinoma: A National Cancer Center Data and Literature-Based Analysis.

Weiming Han, Chen Li, Wei Deng

Pageof 3

Frequent Collaborators

2 joint publications

Xin Wang

2 joint publications

Lei Deng

2 joint publications

Junqiang Chen

2 joint publications

Weiming Han